Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

13 Mar 2012 17:33

RNS Number : 2914Z
Lupus Capital PLC
13 March 2012
 



LUPUS CAPITAL PLC

("Lupus" or "the Group" or "the Company")

 

Director's Dealing

 

The Company was today informed that Mr. Jamie Pike, Non-Executive Chairman of the Company, today purchased 80,000 ordinary shares of 5p each in the Company for a price of 127p per share.

 

Following this purchase, Mr. Pike is interested in a total of 405,000 shares in the Company, representing 0.31% of the total issued share capital of the Company.

 

 

Enquiries:

Lupus Capital plc

Today: 020 7457 2020 (thereafter: 0207 976 8000)

Jamie Pike

Louis Eperjesi

James Brotherton

Collins Stewart Europe Limited

020 7523 8350

Mark Dickenson

Bruce Garrow

College Hill

020 7457 2020

Mike Davies

Helen Tarbet

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFEFWDFESEDD

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.